Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
While the therapy still showed a favourable safety profile and Novo plans further higher-dose trials, todays outcome underscores how small differences in efficacy can have outsized implications for commercial positioning and investor sentiment in weight-loss drug development
Aspire Clinical Labs
Authorship note: MAS and DM contributed equally to this work
weight loss becomes an uphill battle because the body is trying to maintain what it believes to be its ideal weight, called a weight set point
Other sources include Anthem, Elevance, J.D
Meanwhile, Belfast ( 57.14% ), Glasgow ( 63.16% ) and Southampton ( 63.16% ) were the least likely
US$ 25.61
US$ 24.13
US$ 25.23
US$ 27.00
